Lv1
20 积分 2021-02-13 加入
PBPK model of pegylated liposomal doxorubicin to simultaneously predict the concentration–time profile of encapsulated and free doxorubicin in tissues
27天前
已完结
PBPK model of pegylated liposomal doxorubicin to simultaneously predict the concentration–time profile of encapsulated and free doxorubicin in tissues
1个月前
已完结
Demonstration of discriminatory power and prediction of in vivo behaviour of complex liposomal injectable formulation using physiologically based pharmacokinetic modeling
1个月前
已完结
Population pharmacokinetics and pharmacodynamics of L-asparaginase and its impact on the development of pancreatitis and hypersensitivity reactions in children with leukemia under treatment
2个月前
已完结
A generic method for the detection of polyethylene glycol specific IgG and IgM antibodies in human serum
2个月前
已完结
Development of a novel anti-PEG antibody assay enabling investigation of potential immunogenicity triggered by the PEG moiety of biotherapeutics
2个月前
已完结
Statistical Tutorial for Cut‐Point Determination in Immunogenicity Studies
2个月前
已完结
Mechanistic PBPK/PD modeling of free and nano-liposomal irinotecan reveals formulation-specific determinants of disposition and efficacy
3个月前
已完结
Mechanistic PBPK/PD modeling of free and nano-liposomal irinotecan reveals formulation-specific determinants of disposition and efficacy
3个月前
已完结
The curious case of anti-PEG antibodies
3个月前
已完结
皖公网安备34019202002308
